vs
Side-by-side financial comparison of Edible Garden AG Inc (EDBL) and Taysha Gene Therapies, Inc. (TSHA). Click either name above to swap in a different company.
Taysha Gene Therapies, Inc. is the larger business by last-quarter revenue ($5.5M vs $4.1M, roughly 1.3× Edible Garden AG Inc). On growth, Taysha Gene Therapies, Inc. posted the faster year-over-year revenue change (171.3% vs 6.6%). Over the past eight quarters, Taysha Gene Therapies, Inc.'s revenue compounded faster (26.8% CAGR vs 14.8%).
Edible Garden AG Inc is a U.S.-based sustainable agricultural company specializing in hydroponically grown fresh organic herbs, leafy greens, and specialty vegetables. It distributes its pesticide-free produce to leading grocery retailers, food service operators, and direct-to-consumer platforms across North America, prioritizing eco-friendly, low-water farming practices.
Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company specializing in developing adeno-associated virus (AAV)-based gene therapies for rare monogenic central nervous system disorders with high unmet medical needs. Its core pipeline targets serious life-threatening neurological conditions, with primary operations and market focus across North America and European regions.
EDBL vs TSHA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $4.1M | $5.5M |
| Net Profit | — | $-27.9M |
| Gross Margin | -29.0% | — |
| Operating Margin | -138.6% | -516.0% |
| Net Margin | — | -507.8% |
| Revenue YoY | 6.6% | 171.3% |
| Net Profit YoY | — | -48.3% |
| EPS (diluted) | $-109.97 | $-0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $4.1M | $5.5M | ||
| Q3 25 | $2.8M | $0 | ||
| Q2 25 | $3.1M | $2.0M | ||
| Q1 25 | $2.7M | $2.3M | ||
| Q4 24 | $3.9M | $2.0M | ||
| Q3 24 | $2.6M | $1.8M | ||
| Q2 24 | $4.3M | $1.1M | ||
| Q1 24 | $3.1M | $3.4M |
| Q4 25 | — | $-27.9M | ||
| Q3 25 | $-4.0M | $-32.7M | ||
| Q2 25 | $-4.0M | $-26.9M | ||
| Q1 25 | $-3.3M | $-21.5M | ||
| Q4 24 | $-3.1M | $-18.8M | ||
| Q3 24 | $-2.1M | $-25.5M | ||
| Q2 24 | $-1.9M | $-20.9M | ||
| Q1 24 | $-4.0M | $-24.1M |
| Q4 25 | -29.0% | — | ||
| Q3 25 | 9.7% | — | ||
| Q2 25 | 20.2% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 27.1% | — | ||
| Q2 24 | 36.7% | — | ||
| Q1 24 | 0.7% | — |
| Q4 25 | -138.6% | -516.0% | ||
| Q3 25 | -126.3% | — | ||
| Q2 25 | -114.2% | -1347.1% | ||
| Q1 25 | -107.7% | -930.5% | ||
| Q4 24 | -70.8% | -985.8% | ||
| Q3 24 | -57.7% | -1448.4% | ||
| Q2 24 | -27.7% | -1915.4% | ||
| Q1 24 | -123.3% | -713.3% |
| Q4 25 | — | -507.8% | ||
| Q3 25 | -143.6% | — | ||
| Q2 25 | -128.5% | -1353.6% | ||
| Q1 25 | -122.3% | -935.2% | ||
| Q4 24 | -79.5% | -929.0% | ||
| Q3 24 | -79.8% | -1427.5% | ||
| Q2 24 | -45.3% | -1882.0% | ||
| Q1 24 | -127.0% | -705.4% |
| Q4 25 | $-109.97 | $-0.08 | ||
| Q3 25 | $1.38 | $-0.09 | ||
| Q2 25 | $-6.58 | $-0.09 | ||
| Q1 25 | $-2.47 | $-0.08 | ||
| Q4 24 | $-330.78 | $-0.07 | ||
| Q3 24 | $16.32 | $-0.10 | ||
| Q2 24 | $-30.02 | $-0.09 | ||
| Q1 24 | $-341.14 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $319.8M |
| Total DebtLower is stronger | $1.7M | — |
| Stockholders' EquityBook value | $12.5M | $246.9M |
| Total Assets | $20.6M | $343.3M |
| Debt / EquityLower = less leverage | 0.13× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $319.8M | ||
| Q3 25 | — | $297.3M | ||
| Q2 25 | — | $312.8M | ||
| Q1 25 | — | $116.6M | ||
| Q4 24 | — | $139.0M | ||
| Q3 24 | — | $157.7M | ||
| Q2 24 | — | $172.7M | ||
| Q1 24 | — | $124.0M |
| Q4 25 | $1.7M | — | ||
| Q3 25 | $2.7M | — | ||
| Q2 25 | $2.0M | — | ||
| Q1 25 | $2.4M | — | ||
| Q4 24 | $2.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $12.5M | $246.9M | ||
| Q3 25 | $12.9M | $219.0M | ||
| Q2 25 | $1.6M | $248.7M | ||
| Q1 25 | $1.9M | $55.1M | ||
| Q4 24 | $4.1M | $71.5M | ||
| Q3 24 | $3.3M | $88.8M | ||
| Q2 24 | $511.0K | $108.9M | ||
| Q1 24 | $-4.1M | $53.8M |
| Q4 25 | $20.6M | $343.3M | ||
| Q3 25 | $20.1M | $316.6M | ||
| Q2 25 | $21.8M | $333.3M | ||
| Q1 25 | $8.5M | $138.4M | ||
| Q4 24 | $11.9M | $160.4M | ||
| Q3 24 | $8.9M | $180.2M | ||
| Q2 24 | $9.9M | $200.4M | ||
| Q1 24 | $6.3M | $153.0M |
| Q4 25 | 0.13× | — | ||
| Q3 25 | 0.21× | — | ||
| Q2 25 | 1.28× | — | ||
| Q1 25 | 1.24× | — | ||
| Q4 24 | 0.61× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.7M | $-26.7M |
| Free Cash FlowOCF − Capex | $-2.8M | — |
| FCF MarginFCF / Revenue | -66.8% | — |
| Capex IntensityCapex / Revenue | 2.3% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-12.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-2.7M | $-26.7M | ||
| Q3 25 | $-2.4M | $-24.2M | ||
| Q2 25 | $-3.4M | $-20.2M | ||
| Q1 25 | $-3.3M | $-22.0M | ||
| Q4 24 | $-1.8M | $-18.3M | ||
| Q3 24 | $-1.1M | $-21.6M | ||
| Q2 24 | $-4.6M | $-21.5M | ||
| Q1 24 | $-1.1M | $-19.8M |
| Q4 25 | $-2.8M | — | ||
| Q3 25 | $-2.8M | $-24.3M | ||
| Q2 25 | $-3.5M | — | ||
| Q1 25 | $-3.4M | — | ||
| Q4 24 | $-1.9M | $-18.3M | ||
| Q3 24 | $-1.1M | $-21.6M | ||
| Q2 24 | $-4.7M | $-21.7M | ||
| Q1 24 | $-1.1M | $-19.9M |
| Q4 25 | -66.8% | — | ||
| Q3 25 | -98.9% | — | ||
| Q2 25 | -110.8% | — | ||
| Q1 25 | -125.5% | — | ||
| Q4 24 | -48.6% | -905.5% | ||
| Q3 24 | -43.4% | -1210.9% | ||
| Q2 24 | -110.2% | -1951.9% | ||
| Q1 24 | -35.6% | -584.5% |
| Q4 25 | 2.3% | — | ||
| Q3 25 | 14.5% | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 2.9% | — | ||
| Q4 24 | 3.3% | 0.1% | ||
| Q3 24 | 0.4% | 2.0% | ||
| Q2 24 | 2.6% | 18.1% | ||
| Q1 24 | 1.8% | 4.1% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EDBL
| Herbs Produce Floral | $3.6M | 86% |
| Other | $576.0K | 14% |
TSHA
Segment breakdown not available.
